A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the incidence and mortality rates are increasing. Given the limited treatments of HCC and promising application of immunotherapy for cancer, we aimed to identify an immune-related prognostic signature tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chenhao, Weng, Jialei, Gao, Yuan, Liu, Chunxiao, Zhu, Xiaoqiang, Zhou, Qiang, Li, Chia-Wei, Sun, Jialei, Atyah, Manar, Yi, Yong, Ye, Qinghai, Shi, Yi, Dong, Qiongzhu, Liu, Yingbin, Hung, Mien-Chie, Ren, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547263/
https://www.ncbi.nlm.nih.gov/pubmed/36304510
http://dx.doi.org/10.14218/JCTH.2021.00283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547263/
https://www.ncbi.nlm.nih.gov/pubmed/36304510
http://dx.doi.org/10.14218/JCTH.2021.00283

Ejemplares similares